Net Net Stock Overview

Subscribe

To see hundreds more international net nets, consider subscribing

Overview

Seer Inc
Technology
P/NCAV
0.4x
Ticker
SEER
Exchange
NASDAQ
Country
United States
Close
1.81 $
Mkt Cap
115.6M $
EV
83.1M $
NCAV Burn Rate
26.1%
Current Ratio
25.0
Debt/Equity
0.0
EV/REV
4.99x
EV/EBIT
-0.8x
EV/FCF
-1.6x
Dilution
-6.5% p.A
Total Net Income
-305.5M $
Cheapness
100.0%
Seer, Inc. is a life sciences company. The Company is engaged in developing transformative products that open a new gateway to the proteome. Its product, the Proteograph Product Suite (Proteograph), leverages its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid and large-scale access to the proteome. The Proteograph Product Suite is an integrated solution that includes consumables, an automation instrument and software. Its proprietary engineered NPs provide unbiased sampling of intact proteins across the dynamic range of the proteome, capturing molecular information at the peptide-level, including protein variants. It is focused on driving the adoption of the Proteograph by customers in the proteomics and genomics markets. The Proteograph Product Suite is an integrated solution consisting of consumables, an automation instrument, and software to perform biased, deep proteomic analysis at scale in a matter of hours.

Profitability

positive values --- Average negative values

Margins

--- Average

Valuation

positive values --- Average negative values

Dilution

--- Average